Abstract
Indubitably brain is a highly complex organ and has the responsibility to regulate all the cognitive, behavioral, and emotional activities. The meninges and blood–brain barrier act as a safeguard to protect it from pathogenic attacks and blood-borne insults, however, the absence of an indigenous defense mechanism makes it an easy target for many diseases and disorders. Infectious diseases are the main reason for casualties, long-term disability, and economic hardship and negatively impacting healthcare and socioeconomic development on a global scale. For decades, the scientific community struggled to produce medications that can trespass the barriers of the brain and target the intended locations with minimum side effects. However, most of the promising drugs, which proved to enhance brain repair and function at the laboratory stage in animal models, confront numerous hurdles, including specificity, delivery, development of resistance, and toxicity. Thus the development of new techniques is a prerequisite. Nanotechnology is a technique that can modify substances at the molecular level to achieve the desired structure. The nanostructures, interacting with microorganisms, are rapidly transforming the biomedical area, providing benefits in both diagnostic and therapeutic applications. This chapter gives a basic overview of how nanosized materials can be used to diagnose and treat common brain infections.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Abdel Razek AA, Watcharakorn A, Castillo M (2011) Parasitic diseases of the central nervous system. Neuroimaging Clin N Am 21(4):815–841
Adenot M, Merida P, Lahana R (2007) Applications of a blood-brain barrier technology platform to predict CNS penetration of various chemotherapeutic agents. 2. Cationic peptide vectors for brain delivery. Chemotherapy 53(1):73–76
Bai YH, Li JY, Xu JJ, Chen HY (2010) Ultrasensitive electrochemical detection of DNA hybridization using Au/Fe3O4 magnetic composites combined with silver enhancement. Analyst 135(7):1672–1679
Baker LG, Specht CA, Donlin MJ, Lodge JK (2007) Chitosan, the deacetylated form of chitin, is necessary for cell wall integrity in Cryptococcus neoformans. Eukaryot Cell 6(5):855–867
Bargoni A, Cavalli R, Zara GP, Fundarò A, Caputo O, Gasco MR (2001) Transmucosal transport of tobramycin incorporated in solid lipid nanoparticles (SLN) after duodenal administration to rats. Part II—tissue distribution. Pharm Res 43(5):497–502
Bariola JR, Perry P, Pappas PG, Proia L, Shealey W, Wright PW et al (2010) Blastomycosis of the central nervous system: a multicenter review of diagnosis and treatment in the modern era. Clin Infect Dis 50(6):797–804
Bartelmess J, Quinn SJ, Giordani S (2015) Carbon nanomaterials: multi-functional agents for biomedical fluorescence and Raman imaging. Chem Soc Rev 44:4672–4698
Bartomeu Garcia C, Shi D, Webster TJ (2017) Tat-functionalized liposomes for the treatment of meningitis: an in vitro study. Int J Nanomedicine 12:3009–3021
Batrakova EV, Gendelman HE, Kabanov AV (2011) Cell-mediated drug delivery. Expert Opin Drug Deliv 8(4):415–433
Bianco A, Kostarelos K, Prato M (2005) Applications of carbon nanotubes in drug delivery. Curr Opin Chem Biol 9:674–679
Borchorst S, Møller K (2012) The role of dexamethasone in the treatment of bacterial meningitis—a systematic review. Acta Anaesthesiol Scand 56(10):1210–1221
Borgmann K, Rao KS, Labhasetwar V, Ghorpade A (2011) Efficacy of Tat-conjugated ritonavir-loaded nanoparticles in reducing HIV-1 replication in monocyte-derived macrophages and cytocompatibility with macrophages and human neurons. AIDS Res Hum Retrovir 27(8):853–862
Bryan AM, Del Poeta M, Luberto C (2015) Sphingolipids as regulators of the phagocytic response to fungal infections. Mediat Inflamm 2015:640540
Carpio A, Romo ML, Parkhouse RM, Short B, Dua T (2016) Parasitic diseases of the central nervous system: lessons for clinicians and policy makers. Expert Rev Neurother 16(4):401–414
Chen J, Zhang J, Huang L, Lin X, Chen G (2008) Hybridization biosensor using 2-nitroacridone as electrochemical indicator for detection of short DNA species of chronic myelogenous leukemia. Biosens Bioelectron 24(3):349–355
Cheng Y, Dai Q, Morshed RA, Fan X, Wegscheid ML, Wainwright DA, Han Y, Zhang L, Auffinger B, Tobias AL, Rincón E, Thaci B, Ahmed AU, Warnke PC, He C, Lesniak MS (2014) Blood-brain barrier permeable gold nanoparticles: an efficient delivery platform for enhanced malignant glioma therapy and imaging. Small 10(24):5137–5150
Cheung W, Pontoriero F, Taratula O, Chen AM, He H (2010) DNA and carbon nanotubes as medicine. Adv Drug Deliv Rev 62:633–649
Coureuil M, Lécuyer H, Bourdoulous S, Nassif X (2017) A journey into the brain: insight into how bacterial pathogens cross blood-brain barriers. Nat Rev Microbiol 15(3):149–159
Dahm T, Rudolph H, Schwerk C, Schroten H, Tenenbaum T (2016) Neuroinvasion and inflammation in viral central nervous system infections. Mediat Inflamm 2016:8562805
Das M, Dhand C, Sumana G, Srivastava AK, Nagarajan R, Nain L, Iwamoto M, Manaka T, Malhotra BD (2011) Electrophoretic fabrication of chitosan-zirconium-oxide nanobiocomposite platform for nucleic acid detection. Biomacromolecules 12(3):540–547
DeVolder I, Richman L, Conrad AL, Magnotta V, Nopoulos P (2013) Abnormal cerebellar structure is dependent on phenotype of isolated cleft of the lip and/or palate. Cerebellum 12(2):236–244
De Rycker M, Baragana B, Duce SL, Gilbert IH (2018) Challenges and recent progress in drug discovery for tropical diseases. Nature 559(7715):498–506
Dickey SW, Cheung GYC, Otto M (2017) Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance. Nat Rev Drug Discov 16(7):457–471
Dou M, Sanjay ST, Dominguez DC, Zhan S, Li X (2017) A paper/polymer hybrid CD-like microfluidic SpinChip integrated with DNA-functionalized graphene oxide nanosensors for multiplex qLAMP detection. Chem Commun 53:10886–10889
Draz MS, Shafiee H (2018) Applications of gold nanoparticles in virus detection. Theranostics 8:1985–2017
Dutta T, Jain NK (2007) Targeting potential and anti-HIV activity of lamivudine loaded mannosylated poly (propyleneimine) dendrimer. Biochim Biophys Acta 1770(4):681–686
Ekizoğlu M (2017) Infectious diseases of the brain. In: Nanotechnology methods for neurological diseases and brain tumors. Elsevier Science, San Diego, pp 291–315
El Idrissi M, Meyer CE, Zartner L, Meier WP (2018) Nanosensors based on polymer vesicles and planar membranes: a short review. J Nanobiotechnol 16:1–14
Engelborghs S, Niemantsverdriet E, Struyfs H, Blennow K, Brouns R, Comabella M, Dujmovic I, Van Der Flier W, Frölich L, Galimberti D et al (2017) Consensus guidelines for lumbar puncture in patients with neurological diseases. Alzheimers Dement (Amst) 8:111–126
Fabbro A, Villari A, Laishram J, Scaini D, Toma FM, Turco A, Prato M, Ballerini L (2012) Spinal cord explants use carbon nanotube interfaces to enhance neurite outgrowth and to fortify synaptic inputs. ACS Nano 6(3):2041–2055
Gao X, Yang L, Petros JA, Marshall FF et al (2005) In vivo molecular and cellular imaging with quantum dots. Curr Opin Biotechnol 16:63–72
Gao F, Jiang X, Li Q, Fan K (2018) Association of miR-182 expression in amniotic fluid with intrauterine infection and brain injury in premature infants. Exp Ther Med 16(3):1905–1909
Garcia RR, Min Z, Narasimhan S, Bhanot N (2015) Fusarium brain abscess: case report and literature review. Mycoses 58(1):22–26
Gottfredsson M, Perfect JR (2000) Fungal meningitis. Semin Neurol 20(3):307–322
Granerod J, Ambrose HE, Davies NW, Clewley JP, Walsh AL, Morgan D et al (2010) Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis 10(12):835–844
Gupta J, Chakrabarty B, Singh G, Singh S, Kumar A, Xess I, Jauhari P, Gulati S (2021) A rare infective cause of stroke in an immunocompetent child. Brain and Development 43(1):152–156
Hahn MA, Singh AK, Sharma P, Brown SC, Moudgil BM (2011) Nanoparticles as contrast agents for in-vivo bioimaging: current status and future perspectives. Anal Bioanal Chem 399:3–27
Hancock RE, Sahl H-G (2006) Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol 24(12):1551–1557
Haque A, Akcesme FB, Pant AB (2018) A review of zika virus: hurdles toward vaccine development and the way forward. Antivir Ther 23(4):285–293
Honda H, Warren DK (2009) Central nervous system infections: meningitis and brain abscess. Infect Dis Clin N Am 23(3):609–623
Hong W, Zhang Z, Liu L, Zhao Y, Zhang D, Liu M (2018) Brain-targeted delivery of PEGylated nano-bacitracin A against Penicillin-sensitive and -resistant Pneumococcal meningitis: formulated with RVG29 and Pluronic® P85 unimers. Drug Deliv 25:1886–1897
Kalhapure RS, Suleman N, Mocktar C, Seedat N, Govender T (2015) Nanoengineered drug delivery systems for enhancing antibiotic therapy. J Pharm Sci 104(3):872–905
Karampekios S, Hesselink J (2005) Cerebral infections. Eur Radiol 15:485–493
Kaufmann SHE, Dorhoi A, Hotchkiss RS, Bartenschlager R (2018) Host-directed therapies for bacterial and viral infections. Nat Rev Drug Discov 17(1):35–56
Kaya RA, Türkmenoglu ON, Çolak I, Aydin Y (2008) Brain abscess: analysis of results in a series of 51 patients with a combined surgical and medical approach during an 11-year period. Neurosurg Focus 24(6):E9
Kim KS (2008) Mechanisms of microbial traversal of the blood–brain barrier. Nat Rev Microbiol 6(8):625–634
Kleinschmidt-DeMasters BK (2002) Central nervous system aspergillosis: a 20-year retrospective series. Hum Pathol 33(1):116–124
Koeller KK, Shih RY (2017) Viral and prion infections of the central nervous system: radiologic-pathologic correlation: from the radiologic pathology archives. RadioGraphics 37(1):199–233
Köhler JR, Casadevall A, Perfect J (2014) The spectrum of fungi that infects humans. Cold Spring Harb Perspect Med 5(1):a019273
Kreuter J (2014) Drug delivery to the central nervous system by polymeric nanoparticles: what do we know? Adv Drug Deliv Rev 71:2–14
Le Moal G, Landron C, Grollier G, Bataille B, Roblot F, Nassans P et al (2003) Characteristics of brain abscess with isolation of anaerobic bacteria. Scand J Infect Dis 35(5):318–321
Li J, Li L, Wu F, Zhang L, Liu X (2013) Dispersion–precipitation synthesis of nanorod Mn3O4 with high reducibility and the catalytic complete oxidation of air pollutants. Catal Commun 31:52–56
Liechti FD, Grandgirard D, Leib SL (2015) Bacterial meningitis: insights into pathogenesis and evaluation of new treatment options: a perspective from experimental studies. Future Microbiol 10(7):1195–1213
Liu L, Guo K, Lu J, Venkatraman SS, Luo D, Ng KC et al (2008) Biologically active core/shell nanoparticles self-assembled from cholesterol-terminated PEG–TAT for drug delivery across the blood–brain barrier. Biomaterials 29(10):1509–1517
Liu TB, Perlin DS, Xue C (2012) Molecular mechanisms of cryptococcal meningitis. Virulence 3(2):173–181
Mailles A, Stahl JP (2009) Infectious encephalitis in France in 2007: a national prospective study. Clin Infect Dis 49:1838–1847
Mateo-Martí E, Briones C, Pradier CM, Martín-Gago JA (2007) A DNA biosensor based on peptide nucleic acids on gold surfaces. Biosens Bioelectron 22(9–10):1926–1932
McGill F, Heyderman RS, Panagiotou S, Tunkel AR, Solomon T (2017) Acute bacterial meningitis in adults. Lancet 388(10063):3036–3047
Medepalli KK (2008) Advanced nanomaterials for biomedical applications. ProQuest, Cambridge
Metcalf CJE, Lessler J (2017) Opportunities and challenges in modeling emerging infectious diseases. Science 357(6347):149–152
Meylan S, Andrews IW, Collins JJ (2018) Targeting antibiotic tolerance, pathogen by pathogen. Cell 172(6):1228–1238
Mielecki M, Wojtasik J, Zborowska M, Kurzątkowska K, Grzelak K, Dehaen W et al (2013) Oriented immobilization of His-tagged kinase RIO1 protein on redox active N-(IDA-like)-Cu(II) monolayer deposited on gold electrode—the base of electrochemical biosensor. Electrochim Acta 96:147–154
Milovanovic M, Arsenijevic A, Milovanovic J, Kanjevac T, Arsenijevic N (2017) Chapter 14—Nanoparticles in antiviral therapy. In: Grumezescu AM (ed) Antimicrobial nanoarchitectonics. Elsevier, pp 383–410
Mohan S, Srivastava P, Maheshwari SN, Sundar S, Prakash R (2011) Nano-structured nickel oxide based DNA biosensor for detection of visceral leishmaniasis (Kala-azar). Analyst 136(13):2845–2851
Mukherjee A, Shim Y, Myong Song J (2016) Quantum dot as probe for disease diagnosis and monitoring. Biotechnol J 11(1):31–42
Murthy JM (2007) Fungal infections of the central nervous system: the clinical syndromes. Neurol India 55(3):221–225
Muzumdar D, Jhawar S, Goel A (2011) Brain abscess: an overview. Int J Surg 9(2):136–144
Nalwa HS (1999) Handbook of nanostructured materials and nanotechnology, vol 1. Academic, San Diego, pp 1–3
Nassif X, Bourdoulous S, Eugène E, Couraud P-O (2002) How do extracellular pathogens cross the blood–brain barrier? Trends Microbiol 10(5):227–232
Nau R, Soto A, Brück W (1999) Apoptosis of neurons in the dentate gyrus in humans suffering from bacterial meningitis. J Neuropathol Exp Neurol 58(3):265–274
Ngowi EE, Wang YZ, Qian L, Helmy Y, Anyomi B, Li T, Zheng M, Jiang ES, Duan SF, Wei JS, Wu DD, Ji XY (2021) The application of nanotechnology for the diagnosis and treatment of brain diseases and disorders. Front Bioeng Biotechnol 2(9):629832
Niemeyer CM, Mirkin CA (2004) Nanobiotechnology: concepts, applications and perspectives, vol 1. Wiley, Weinheim
Ørsted I, Gertsen J, Schønheyder H, Jensen J, Nielsen H (2011) Mycoplasma salivarium isolated from brain abscesses. Clin Microbiol Infect 17(7):1047–1049
Parboosing R, Maguire GE, Govender P et al (2012) Nanotechnology and the treatment of HIV infection. Viruses 4:488–520
Pardi N, Hogan MJ, Porter FW, Weissman D (2018) mRNA vaccines—a new era in vaccinology. Nat Rev Drug Discov 17(4):261–279
Patel K, Clifford DB (2014) Bacterial brain abscess. Neurohospitalist 4(4):196–204
Patel MK, Solanki PR, Seth S, Gupta S, Khare S, Kumar A, Malhotra BD (2009) CtrA gene based electrochemical DNA sensor for detection of meningitis. Electrochem Commun 11(5):969–973
Patel MK, Solanki PR, Kumar A, Khare S, Gupta S, Malhotra BD (2010) Electrochemical DNA sensor for Neisseria meningitidis detection. Biosens Bioelectron 25(12):2586–2591
Pedroso VS, Vilela MC, Santos PC, Cisalpino PS, Rachid MA, Teixeira AL (2013) Traffic of leukocytes and cytokine upregulation in the central nervous system in a murine model of neuroparacoccidioidomycosis. Mycopathologia 176(3–4):191–199
Perumal V, Saheed MSM, Mohamed NM, Murthe SS, Gopinath SC, Chiu J-M (2018) Gold nanorod embedded novel 3D graphene nanocomposite for selective bio-capture in rapid detection of Mycobacterium tuberculosis. Biosens Bioelectron 116:116–122
Pulzova L, Bhide MR, Andrej K (2009) Pathogen translocation across the blood-brain barrier. FEMS Immunol Med Microbiol 57(3):203–213
Qin Y, Chen H, Yuan W, Kuai R, Zhang Q, Xie F et al (2011) Liposome formulated with TAT-modified cholesterol for enhancing the brain delivery. Int J Pharm 419(1):85–95
Raoultm D, Al Masalma M, Armougom F, Scheld WM, Dufour H, Roche P-H et al (2009) The expansion of the microbiological spectrum of brain abscesses with use of multiple 16S ribosomal DNA sequencing. Clin Infect Dis 48(9):1169–1178
Ribes S, Djukic M, Eiffert H (2014) Strategies to increase the activity of microglia as efficient protectors of the brain against infections. Front Cell Neurosci 8:138
Rizvi SMD, Hussain T, Ahmed ABF, Alshammari TM, Moin A, Ahmed MQ, Barreto GE, Kamal MA, Ashraf GM (2018) Gold nanoparticles: a plausible tool to combat neurological bacterial infections in humans. Biomed Pharmacother 107:7–18
Roberts F, Hobbs H, Jessop H, Bozzolini C, Burman J, Greco R, Ismail A, Kazmi M, Kirgizov K, Mancardi G, Mawson S, Muraro PA, Puyade M, Saccardi R, Withers B, Verhoeven B, Sharrack B, Snowden JA (2020) Rehabilitation before and after autologous haematopoietic stem cell transplantation (AHSCT) for patients with multiple sclerosis (MS): consensus guidelines and recommendations for best clinical practice on behalf of the autoimmune diseases working party, nurses group, and patient advocacy committee of the European Society for Blood and Marrow Transplantation (EBMT). Front Neurol 11:556141
Rousselle C, Clair P, Smirnova M, Kolesnikov Y, Pasternak GW, Gac-Breton S et al (2003) Improved brain uptake and pharmacological activity of dalargin using a peptide-vector-mediated strategy. J Pharmacol Exp Ther 306(1):371–376
Safardoust-Hojaghan H, Salavati-Niasari M, Amiri O, Hassanpour M (2017) Preparation of highly luminescent nitrogen doped graphene quantum dots and their application as a probe for detection of Staphylococcus aureus and E. coli. J Mol Liq 241:1114–1119
Salouti M, Ahangari A (2014) Nanoparticle based drug delivery systems for treatment of infectious diseases. In: Application of nanotechnology in drug delivery. InTech, pp 155–192
Scheller FW, Bier FF, Pfeiffer D (1995) Biosensoren: grundlagen und anwendungen. TM-Tech Mess 62:213–219
Schwerk C, Tenenbaum T, Kim KS, Schroten H (2015) The choroid plexus—a multi-role player during infectious diseases of the CNS. Front Cell Neurosci 9:80
Scully EP, Baden LR, Katz JT (2008) Fungal brain infections. Curr Opin Neurol 21(3):347–352
Segura M, Zheng H, de Greeff A, Gao GF, Grenier D, Jiang Y, Lu C, Maskell D, Oishi K, Okura M, Osawa R, Schultsz C, Schwerk C, Sekizaki T, Smith H, Srimanote P, Takamatsu D, Tang J, Tenenbaum T, Tharavichitkul P, Hoa NT, Valentin- Weigand P, Wells JM, Wertheim H, Zhu B, Gottschalk M, Xu J (2014) Latest developments on Streptococcus suis: an emerging zoonotic pathogen: part 1. Future Microbiol 9(4):441–444
Selvan ST, Padmanabhan P, Gulyás BZ (2019) Nanotechnology-based diagnostics and therapy for pathogen-related infections in the CNS. ACS Chem Neurosci 11:2371–2377
Sharifi S, Behzadi S, Laurent S, Laird Forrest M, Stroeve P, Mahmoudi M (2012) Toxicity of nanomaterials. Chem Soc Rev 41:2323–2343
Sharma RR (2010) Fungal infections of the nervous system: current perspective and controversies in management. Int J Surg 8(8):591–601
Sharma G, Lakkadwala S, Modgil A, Singh J (2016) The role of cell-penetrating peptide and transferring on enhanced delivery of drug to brain. Int J Mol Sci 17(6):806
Singh L, Kruger HG, Maguire GEM, Govender T, Parboosing R (2017) The role of nanotechnology in the treatment of viral infections. Ther Adv Infect Dis 4(4):105–131
Sohaebuddin SK, Thevenot PT, Baker D, Eaton JW, Tang L (2010) Nanomaterial cytotoxicity is composition, size, and cell type dependent. Part Fibre Toxicol 7:22
Spector R (1990) Advances in understanding the pharmacology of agents used to treat bacterial meningitis. Pharmacology 41(3):113–118
Swanson PA, McGavern DB (2015) Viral diseases of the central nervous system. Curr Opin Virol 11:44–54
Tak M, Gupta V, Tomar M (2014) Flower-like ZnO nanostructure based electrochemical DNA biosensor for bacterial meningitis detection. Biosens Bioelectron 15(59):200–207
Tiwari RP, Garg SK, Bharmal RN, Kartikeyan S, Bisen PS (2007) Rapid liposomal agglutination card test for the detection of antigens in patients with active tuberculosis. Int J Tuberc Lung Dis 11:1143–1151
Tiwari D, Haque S, Tiwari RP, Jawed A, Govender T, Kruger HG (2017) Fast and efficient detection of tuberculosis antigens using liposome encapsulated secretory proteins of Mycobacterium tuberculosis. J Microbiol Immunol Infect 50:189–198
Tyagi M, Tomar M, Gupta V (2013) NiO nanoparticle-based urea biosensor. Biosens Bioelectron 41:110–115
Van Furth A, Roord JJ, Van Furth R (1996) Roles of proinflammatory and anti-inflammatory cytokines in pathophysiology of bacterial meningitis and effect of adjunctive therapy. Infect Immun 64(12):4883
Vishwanath S, Shenoy PA, Gupta A, Menon G, Chawla K (2016) Brain abscess with anaerobic Gram negative bacilli: case series. J Case Rep 6(4):467–474
Wagner V, Dullaart A, Bock A-K, Zweck A (2006) The emerging nanomedicine landscape. Nat Biotechnol 24(10):1211–1217
Walker M, Kublin JG, Zunt JR (2006) Parasitic central nervous system infections in immunocompromised hosts: malaria, microsporidiosis, leishmaniasis, and African trypanosomiasis. Clin Infect Dis 42(1):115–125
Wang H, Xu K, Liu L, Tan JP, Chen Y, Li Y et al (2010) The efficacy of self-assembled cationic antimicrobial peptide nanoparticles against Cryptococcus neoformans for the treatment of meningitis. Biomaterials 31(10):2874–2881
Willing BP, Russell SL, Finlay BB (2011) Shifting the balance: antibiotic effects on host-microbiota mutualism. Nat Rev Microbiol 9(4):233–243
Xiang HB, Liu C, Liu TT, Xiong J (2014) Central circuits regulating the sympathetic outflow to lumbar muscles in spinally transected mice by retrograde transsynaptic transport. Int J Clin Exp Pathol 7(6):2987–2997
Yin H, Xu Z, Wang M, Zhang X, Ai S (2013) An electrochemical biosensor for assay of DNA methyltransferase activity and screening of inhibitor. Electrochim Acta 89:530–536
Zaidi S, Misba L, Khan AU (2017) Nano-therapeutics: a revolution in infection control in post antibiotic era. Nanomedicine 13(7):2281–2301
Zhang J-R, Tuomanen E (1999) Molecular and cellular mechanisms for microbial entry into the CNS. J Neurovirol 5(6):591–603
Zhang W, Yang T, Zhuang X, Guo Z, Jiao K (2009) An ionic liquid supported CeO2 nanoshuttles-carbon nanotubes composite as a platform for impedance DNA hybridization sensing. Biosens Bioelectron 24(8):2417–2422
Zhang S, Chen Y, Liang J, Wang S, Liu L, Liu S (2017) Nanoformulated antimicrobial agents for central nervous system infections. J Nanosci Nanotechnol 17(12):8683–8698(16)
Zhou L, Qiu T, Lv F, Liu L, Ying J, Wang S (2018) Self-assembled nanomedicines for anticancer and antibacterial applications. Adv Healthc Mater 7(20):1800670
Zong J, Cobb SL, Cameron NR (2017) Peptide-functionalized gold nanoparticles: versatile biomaterials for diagnostic and therapeutic applications. Biomater Sci 5:872–886
Zou L-l, Ma J-L, Wang T, Yang T-B, Liu C-B (2013) Cell-penetrating peptide-mediated therapeutic molecule delivery into the central nervous system. Curr Neuropharmacol 11(2):197–208
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive licence to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Singh, M.P. et al. (2022). Brain Infectious Diseases and Nanotherapy. In: Hameed, S., Rehman, S. (eds) Nanotechnology for Infectious Diseases. Springer, Singapore. https://doi.org/10.1007/978-981-16-9190-4_26
Download citation
DOI: https://doi.org/10.1007/978-981-16-9190-4_26
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-16-9189-8
Online ISBN: 978-981-16-9190-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)